Latest News and Press Releases

Boston, Oct. 22, 2025 (GLOBE NEWSWIRE) -- According to the latest study from BCC Research, “Molecular Diagnostics: Technologies and Global Markets” is projected to grow from $23 billion in 2025 to...

Avance Clinical Launches Dedicated Center of Excellence to Accelerate Early Phase Biotech Trials

Pneumagen’s intranasal broad-spectrum antiviral therapy reduced infection, improved symptoms and severity and reduced viral load in a Phase II influenza study in data published in the high-impact,...

Avance Clinical is delivering the GlobalReady solution to help biotechs de-risk, conserve capital and accelerate drug development programs.

The Global Virus Network believes that systemic inadequacies and vulnerabilities persist, which threaten public health on a global scale.

GVN calls on world governments to address the threat of H5N1 avian influenza by enhancing surveillance, implementing biosecurity measures, and preparing

Dr. Rietiker has considerable experience in the life sciences industry, including leadership positions in global pharmaceutical and medical device companies, and has overseen multiple major company...

Their appointment was initiated by the outgoing board of directors. The four new members will bring many years of experience in the biotech and pharmaceutical industry, especially in research and...

Congress will take place April 21-24, 2025, in Washington, D.C.COPENHAGEN, Denmark, April 10, 2025 - Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio company specializing in...

Wilmington, Delaware, Feb. 16, 2025 (GLOBE NEWSWIRE) -- Allied Market Research published a report, titled, "Vaccine Adjuvants Market by Type (Immunostimulants, Vehicles and Mucosal Adjuvants),...